Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

Orforglipron carried more side effects, however ...

Stroke is a leading cause of death and disability worldwide, with staggering statistics that demand urgent attention. Every year, approximately 12.2 million new strokes are diagnosed globally, and one ...

The provincial and federal governments signed a four-year agreement last year to implement a national PharmaCare initiative ...

Diabetes is the most common cause of chronic kidney disease (CKD). Around 33 percent of adults with diabetes also have CKD. When diabetes causes CKD, its sometimes called diabetic kidney disease.

Living with diabetes doesn’t have to mean accepting a lifetime of increasing medication doses and constant worry about blood sugar spikes. While traditional medical approaches focus heavily on ...

Read more about why patients with type 2 diabetes will now be offered SGLT-2 inhibitors much earlier in the treatment process ...

In the United States, over 30 million people suffer from diabetes, while nearly 98 million are classified as pre-diabetic. Unfortunately, rather than addressing the fundamental lifestyle factors that ...

Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re one of the millions of adults worldwide who heard about Novo Nordisk’s ...

Novo Nordisk is slashing the list prices of its flagship weight-loss and diabetes drugs, including Wegovy and Ozempic, by up ...

There are many myths about diabetes that are not true. An Apollo doctor clarified some of these misconceptions, including the ...